Detalhe da pesquisa
1.
Integration of pan-omics technologies and three-dimensional in vitro tumor models: an approach toward drug discovery and precision medicine.
Mol Cancer;
23(1): 50, 2024 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38461268
2.
Increased Gene Expression of C1orf74 Is Associated with Poor Prognosis in Cervical Cancer.
Cells;
12(21)2023 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37947608
3.
Crizotinib induces Par-4 secretion from normal cells and GRP78 expression on the cancer cell surface for selective tumor growth inhibition.
Am J Cancer Res;
13(3): 976-991, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37034206
4.
Peroxiredoxin IV plays a critical role in cancer cell growth and radioresistance through the activation of the Akt/GSK3 signaling pathways.
J Biol Chem;
298(7): 102123, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35697073
5.
Tumor Suppressor Par-4 Regulates Complement Factor C3 and Obesity.
Front Oncol;
12: 860446, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35425699
6.
Role of the splenic microenvironment in chronic lymphocytic leukemia development in Eµ-TCL1 transgenic mice.
Leuk Lymphoma;
63(8): 1810-1822, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35258388
7.
Integration of liquid biopsy and pharmacogenomics for precision therapy of EGFR mutant and resistant lung cancers.
Mol Cancer;
21(1): 61, 2022 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35209919
8.
Ru(II)/amino acid complexes inhibit the progression of breast cancer cells through multiple mechanism-induced apoptosis.
J Inorg Biochem;
226: 111625, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34655962
9.
Amino-Substituted 3-Aryl- and 3-Heteroarylquinolines as Potential Antileishmanial Agents.
J Med Chem;
64(16): 12152-12162, 2021 08 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34355566
10.
Value added by an inter-continental cancer consortium.
Genes Cancer;
12: 65-68, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34046148
11.
Therapeutic opportunities in cancer therapy: targeting the p53-MDM2/MDMX interactions.
Am J Cancer Res;
11(12): 5762-5781, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35018225
12.
Develop a High-Throughput Screening Method to Identify C-P4H1 (Collagen Prolyl 4-Hydroxylase 1) Inhibitors from FDA-Approved Chemicals.
Int J Mol Sci;
21(18)2020 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32927660
13.
Par-4 regulates autophagic cell death in human cancer cells via upregulating p53 and BNIP3.
Biochim Biophys Acta Mol Cell Res;
1867(7): 118692, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32135176
14.
Development of a novel prostate apoptosis response-4 (Par-4) protein entity with an extended duration of action for therapeutic treatment of cancer.
Protein Eng Des Sel;
32(3): 159-166, 2019 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31711233
15.
Par-4 overexpression impedes leukemogenesis in the Eµ-TCL1 leukemia model through downregulation of NF-κB signaling.
Blood Adv;
3(8): 1255-1266, 2019 04 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30987970
16.
GRP78 Is a Targetable Receptor on Cancer and Stromal Cells.
EBioMedicine;
33: 2-3, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29997052
17.
Chronic Lymphocytic Leukemia-Derived IL-10 Suppresses Antitumor Immunity.
J Immunol;
200(12): 4180-4189, 2018 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29712773
18.
Novel role of prostate apoptosis response-4 tumor suppressor in B-cell chronic lymphocytic leukemia.
Blood;
131(26): 2943-2954, 2018 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29695515
19.
Neoadjuvant administration of hydroxychloroquine in a phase 1 clinical trial induced plasma Par-4 levels and apoptosis in diverse tumors.
Genes Cancer;
9(5-6): 190-197, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30603055
20.
A Naturally Generated Decoy of the Prostate Apoptosis Response-4 Protein Overcomes Therapy Resistance in Tumors.
Cancer Res;
77(15): 4039-4050, 2017 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28625975